HPV Testing And Pap Test Market Size, Share & Trends Report

HPV Testing And Pap Test Market Size, Share & Trends Analysis Report By Test Type, By Application (Cervical Cancer, Vaginal Cancer), By Product, By Technology, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: 978-1-68038-895-4
  • Number of Pages: 112
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the HPV testing and pap test market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for HPV testing and pap test market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of HPV testing and pap test market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

HPV Testing And Pap Test Market Categorization:

The HPV testing and pap test market was categorized into six segments, namely test type (Pap Test, HPV Test), application (Cervical Cancer Screening, Vaginal Cancer Screening), product (Instruments, Consumables, Services), technology (PCR, Immunodiagnostics), end-use (Hospitals & Clinics, Laboratories), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The HPV testing and pap test market was segmented into test type, application, product, technology, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The HPV testing and pap test market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

HPV testing and pap test market companies & financials:

The HPV testing and pap test market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • ABBOTT - Abbott is engaged in the creation, advancement, production, and promotion of several medical goods. The company's four reportable segments are cardiovascular & neuromodulation products; established pharmaceutical goods; nutritional products; and diagnostic products. Via its diagnostics division, the firm provides HPV testing items, such as assays and devices. Through its distribution centers, public warehouses, and third-party distributors, the firm advertises and distributes its goods directly to healthcare facilities such as hospitals, clinics, doctor's offices, commercial laboratories, blood banks, government agencies, and therapeutic companies.

  • QIAGEN - The international corporation Qiagen develops and markets a variety of sample and assay technologies for use in academic, pharmaceutical, and applied testing settings as well as molecular diagnostics. operational under the Financial Accounting Standards Board, the company has one operational segment. The corporation uses its subsidiaries to sell its goods in more than 130 nations.

  • BECTON, DICKINSON AND COMPANY (BD) - Clinical laboratories, life sciences researchers, and the healthcare sector are all served by the medical technology business BD. The firm produces and sells a broad variety of laboratory equipment, medical supplies, diagnostic tools, and medical gadgets. The company is divided into three business segments: BD Biosciences, BD Diagnostics, and BD Medical. Products for the safe collection and transportation of diagnostic specimens, as well as reagent systems and devices that precisely identify a wide range of illnesses, infectious diseases, and cancers related to healthcare, are offered by the BD Diagnostics business. The diagnostic systems market offers completely automated molecular systems that are user-friendly, quick to produce results, and need little hands-on time. The business maintains offices in over 50 nations.

  • QUEST DIAGNOSTICS, INC. - Diagnostic solutions and diagnostics information services are the two reportable categories under which Quest Diagnostics, Inc. offers diagnostic tests and services. The business also has full-service laboratories, fast-response laboratories, and patient service centers. Quest Diagnostics offers regular medical, esoteric, and non-hospital-based anatomic pathology diagnostic services in addition to drug abuse screening. The firm offers clinical trial testing, wellness & risk management, healthcare IT, and diagnostic testing services. Under many names, including MedXM, AmeriPath, Athena Diagnostics, Quanum Solutions, Dermpath Diagnostics, and ExamOne, Quest Diagnostics provides goods and services. The firm has many clinical laboratories and 2,200 patient sites throughout the United States. Additionally, the business runs clinical labs in England, Mexico, and India, among other places.

  • HOLOGIC, INC. - The primary purpose of Hologic, Inc.'s development, production, and marketing activities is the provision of diagnostic solutions that facilitate human illness diagnosis. The company's five business segments-Medical Aesthetics, Breast Health, Skeletal Health, and GYN Surgical-are used to run its operations. The corporation uses a network of independent sales representatives and distributors in addition to direct sales and service staff to promote its goods.

  • F. HOFFMANN-LA ROCHE LTD. - The international healthcare corporation F. Hoffmann-La Roche Ltd. is divided into two business segments: pharmaceuticals and diagnostics. The business produces test systems, test kits, and molecular diagnostic reagents through research and development. Furthermore, it offers automated tools, software, IT solutions, and consumables-all of which are widely utilized in in vitro diagnostics and research. The firm serves patients, practicing physicians, hospitals, private medical laboratories, and research laboratories. It now has operations in over 100 countries and is a subsidiary of Roche Holding AG.

  • FEMASYS, INC. - The biotechnology business Arbor Vita Corporation is dedicated to the creation, exploration, and marketing of diagnostic goods. The business provides testing for influenza and cancer detection. The company's OncoE6 Cervical Test aids in the early detection of cervical cancer. Since it's a privately held business, its financials are kept confidential.

  • ARBOR VITA CORPORATION - The biotechnology business Arbor Vita Corporation is dedicated to the creation, exploration, and marketing of diagnostic goods. The business provides testing for influenza and cancer detection. The company's OncoE6 Cervical Test aids in the early detection of cervical cancer. Since it's a privately held business, its financials are kept confidential.

  • NURX, INC - A telemedicine startup called NURX, Inc. provides simple internet access to prescription drugs and home testing equipment. The company's platform offers an end-to-end, cost-effective digital health experience by integrating a telemedicine platform, an owned-and-operated pharmacy, and a network of partner physicians. The firm provides a variety of home testing kits and treatments for sexually transmitted illnesses, including herpes, HPV, and other conditions. The top rivals of the business are Lemonaid Health, Maven, Roman, and Stork Club Fertility.

  • SEEGENE, INC. - The in vitro medical diagnostics firm Seegene, Inc. focuses on in vitro applications including molecular diagnostics, respiratory pathogen detection, infectious illness detection, companion diagnostics, nucleic acid testing, and infectious disease detection. The DPO technology for multiple target amplification, the TOCE technology for multiple target detection, and the MuDT technology for multiple target real-time analysis comprise the company's multiplex real-time PCR technologies. Additionally, the firm provides tests for tropical fever, meningitis, HPV, gastrointestinal tract infections, respiratory tract infections, TB, and cancer diagnostics. The business maintains subsidiaries throughout Europe, the Middle East, and North and South America.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

HPV Testing And Pap Test Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

HPV Testing And Pap Test Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon